Recurrent Hypophysitis: Identifying Risk Factors and Effective Management Strategies
Journal of Neurological Surgery Part B: Skull Base · 01.02.2024 · 85 (S 01 S 01) · S1-S398
DOI: 10.1055/s-0044-1780307 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.02.2024. Verfasst von Mohammad Bilal Alsavaf und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Hypophysitis, a rare and diagnostically challenging inflammatory disorder, lacks established treatment guidelines. Its multifaceted etiologies, diverse pathological manifestations, imaging intricacies, and variable treatment responses pose formidable challenges for rheumatologists, endocrinologists, and neurosurgeons. In this study, we share our clinical insights into hypophysitis management, shedding light on the impact of etiologies, blood biomarkers, and pathological subtypes on diagnostic accuracy and treatment outcomes. Methodology: We conducted a retrospective cohort study encompassing 12 adult patients diagnosed with hypophysitis and treated at a specialized tertiary medical center. Patient demographics, treatment modalities, laboratory findings, histopathological results, and pre- and post-treatment radiological images were meticulously analyzed. Data analysis was performed using Jamovi edition 2.4.8.
Results
Our cohort comprised 12 individuals (mean age: 46.9 ± 13.8 years; 50% male). Predominant initial symptoms included headaches (83.3%), polyuria/polydipsia (83.3%), nausea (66.7%), fatigue (66.7%), visual disturbances (58.3%), and decreased libido (41.7%). Coexisting medical conditions were observed in 8 patients, including diabetes mellitus (4 cases), rheumatoid arthritis (2 cases), Wegener’s granulomatosis (1 case), sarcoidosis (1 case), and a patient with a history of craniopharyngioma surgery (1 case). Ten patients underwent endoscopic endonasal surgery with the goals of diagnosis and decompression whereas 2 cases were managed medically. All surgically treated patients presented with panhypopituitarism preoperatively, with functional improvement observed in only one case after a year of follow-up. The mean follow-up duration was 54 ± 47 months. Recurrence occurred in 3 cases (30%) and was significantly associated with younger age (34.7 ± 12.6 years vs. 54.1 ± 12 years; p = 0.048) and a higher annual change in BMI (3.18 ± 1.83 vs. 0.8 ± 0.6; p = 0.011). Patients with recurrent disease and uncontrolled diabetes mellitus (HbA1c average of 10) showed a proclivity for multiple recurrences. Histopathological subtypes (lymphocytic versus granulocytic) did not significantly impact recurrence rates. A complete hypophysectomy was performed in selected cases. Radiation therapy demonstrated an efficacy in managing 3 resistant cases. Blood biomarkers were not found to be diagnostically informative or predictive of pathological subtype or treatment response.
Conclusion
Current treatment strategies for hypophysitis predominantly involve corticosteroid therapy, although diagnostic precision remains challenging due to the wide imaging spectrum. Surgical intervention confirms the diagnosis and can be beneficial decreasing mass effect and improving some of the symptomatology. Vigilant control of blood glucose levels and BMI assumes paramount importance in mitigating recurrence, casting uncertainty on the long-term effects of corticosteroid administration. Younger patients bear a higher risk of recurrence, warranting close follow-up and consideration of reoperation with complete hypophysectomy as well as adjunctive treatments such as low-dose radiation therapy particularly for cases with resistant inflammatory findings beyond the pituitary gland. Publication History Article published online: 05 February 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Alsavaf, M. B., Ustun, B. N., Salem, E. H., Maithrea, S., Abouammo, M. D., Tangsrivimol, J. A., Hardesty, D. A., Carrau, R. L., Ghalib, L., & Prevedello, D. M. (2024). Recurrent Hypophysitis: Identifying Risk Factors and Effective Management Strategies. Journal of Neurological Surgery Part B: Skull Base, 85(S 01 S 01), S1-S398. https://doi.org/10.1055/s-0044-1780307
Vancouver
Alsavaf MB, Ustun BN, Salem EH, Maithrea S, Abouammo MD, Tangsrivimol JA, et al. Recurrent Hypophysitis: Identifying Risk Factors and Effective Management Strategies. Journal of Neurological Surgery Part B: Skull Base. 2024;85(S 01 S 01):S1-S398. doi:10.1055/s-0044-1780307
BibTeX
@article{Alsavaf2024,
author = {Alsavaf, Mohammad Bilal and Ustun, Bedriye Nur and Salem, Eman H. and Maithrea, S.N. and Abouammo, Moataz D. and Tangsrivimol, Jonathan A. and Hardesty, Douglas A. and Carrau, Ricardo L. and Ghalib, Luma and Prevedello, Daniel M.},
title = {Recurrent Hypophysitis: Identifying Risk Factors and Effective Management Strategies},
journal = {Journal of Neurological Surgery Part B: Skull Base},
year = {2024},
volume = {85},
number = {S 01 S 01},
pages = {S1--S398},
doi = {10.1055/s-0044-1780307}
}
EUVIMED